Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Dentsply Sirona Forecasts Fiscal Year 2024 Sales Of $3.96B-$4.02B Versus Consensus Of $4.00B And Adjusted EPS Of $2.00-$2.10 Versus Consensus Of $2.05

Author: Benzinga Newsdesk | February 29, 2024 07:06am

Posted In: XRAY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist